Tesamorelin, 10mg
$108.00
- Product Name: Tesamorelin
- Sequence: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu
- Molecular Formula: C223H370N72O69S
- Molecular Weight: 5196 g/mol
- Research Only: Yes
- Form: Lyophilized Solid
- Purity: >99%
- Storage: Keep refrigerated upon reconstitution
Some COAs may contain redactions of confidential or proprietary information. These redactions do not impact or obscure any analytical data, including compound identity, purity, or test results.
| Title | Range | Discount |
|---|---|---|
| 3-4 vials 5% off | 3 - 4 | 5% |
| Tiered Bulk Discount | 5 - 7 | 10% |
| Tiered Bulk Discount | 8 - 11 | 12% |
| Tiered Bulk Discount | 12 - 15 | 15% |
| Tiered Bulk Discount | 16 + | 20% |
- Tesamorelin is a stabilized analog of growth hormone–releasing hormone (GHRH) that has been studied in research settings for its interaction with the growth hormone (GH) and insulin-like growth factor 1 (IGF-1) axis. Experimental investigations have explored its association with metabolic signaling pathways, including those related to lipid metabolism and body composition.
Metabolic and Adipose Tissue Research
Tesamorelin has been examined in clinical and preclinical studies for its relationship with visceral adipose tissue (VAT) and lipid-related parameters. In controlled settings, research has reported associations with changes in body composition metrics, including measures of central adiposity. These findings are population-specific and may vary depending on study design and duration.
Hepatic Research
Studies have investigated tesamorelin in models involving liver metabolism, including conditions associated with hepatic fat accumulation. Research has explored its interaction with pathways related to lipid metabolism, inflammation, and cellular energy processes in hepatic tissue. Observations are derived from controlled clinical and experimental settings and remain under investigation.
Lipid and Cardiovascular Research
Tesamorelin has been evaluated for its association with lipid profiles and cardiovascular risk markers in certain study populations. Experimental findings suggest potential interactions with cholesterol-related pathways and metabolic signaling, though the clinical significance of these observations is not fully established.
Endocrine and Metabolic Signaling
As a GHRH analog, tesamorelin has been shown in research settings to influence GH and IGF-1 levels. Studies have explored downstream effects on metabolic and physiological signaling pathways, including those related to energy balance and tissue regulation. These effects are context-dependent and require further validation.
Neurocognitive and Additional Research
Tesamorelin has also been studied in relation to neurocognitive and systemic outcomes in specific populations. Findings in this area are limited and have shown variable results across different study designs.
Tesamorelin is not approved by the U.S. Food and Drug Administration for human use, and its safety, efficacy, and pharmacological profile have not been established in approved FDA clinical trials. It is not intended to diagnose, treat, cure, or prevent any disease.
Lyophilized Peptides
These peptides are freeze-dried, a process that not only extends shelf life but also preserves the purity and integrity of the peptides during storage.
Disclaimer: For Research Purposes only
This content is provided strictly for research purposes and does not constitute an endorsement or recommendation for the non-laboratory application or improper handling of peptides designed for research. The information, including discussions about specific peptides and their researched benefits, is presented for informational purposes only and must not be construed as health, clinical, or legal guidance, nor an encouragement for non-research use. Peptides described here are solely for use in structured scientific study by authorized individuals. We advise consulting with research experts, medical practitioners, or legal counsel prior to any decisions about obtaining or utilizing these peptides. The expectation of responsible, ethical utilization of this information for legitimate investigative and scholarly objectives is paramount. This notice is dynamic and governs all provided content on research peptides.
